Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-60
SponsorAlloSource

About this trial

The primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients are ≥12 years and ≤ 60 years of age at the time of surgery.

Symptomatic patient presenting with moderate to severe pain in the index knee - unresponsive to conservative treatment (i.e., medication, bracing, physical therapy) and/or previous surgical intervention OR unsalvageable lesion that requires transplantation at the discretion of the treating physician.

Radiographically diagnosed, by MRI or CT scans, or through arthroscopy, to have a cartilage defect on the femoral condyle between 0.9-8.0 cm2 in size.

Will be having an osteochondral transplant procedure.

Disqualifiers

Bipolar articular cartilage involvement (kissing lesions) of the ipsilateral compartment (i.e., > than ICRS Grade 2 on the opposing articular surface).

Has had a prior osteochondral allograft transplant procedure in the same knee.

Will be receiving a meniscus allograft transplantation in the same procedure.

Body Mass Index (BMI)of ≥ 35 kg/m2.

Trial design

Design model

Single group

Treatments tested in this trial

  • osteochondral transplant on the femoral condyle

    Procedure/Surgery

    Patients between the ages of ≥12 years and ≤ 60 years who have a symptomatic full-thickness cartilage lesion (Grade 3 or 4) on the femoral condyle, in a mechanically stable knee, or is being mechanically stabilized in the same procedure, between 0.9-8.0 cm2 in size, and cystic changes requiring osseous repair, as confirmed by MRI , CT scan, or arthroscopy and will undergo a osteochondral transplant by removing the damaged cartilage and replacing that cartilage with a cryopreserved osteochondral allograft core.

Treatment groups

68 Participants
are divided into 1 treatment group
Group A: Osteochondral transplant on the femoral condyleExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

International Knee Documentation Committee (IKDC) score

Change of physical functioning and pain from baseline as assessed by the subjective International Knee Documentation Committee (IKDC) score. Scores are reported on a 0-100 scale, with low scores indicating worse outcomes and higher scores indicating better outcomes.

Time frame
3 months, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months post procedure

Secondary outcomes

1

Knee Injury and Osteoarthritis Outcome Score (KOOS)

Change from baseline (pre-operative) Scores are reported on a 0-100 scale, with low scores indicating worse outcomes and higher scores indicating better outcomes.

Time frame
3 months, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months
2

Assessment of repair cartilage structure

Assessment of repair cartilage structure, using Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scores, as measured by Magnetic Resonance Imaging (MRI). Scores are reported on a 0-100 scale, with low scores indicating worse outcomes and higher scores indicating better outcomes.

Time frame
12 months, 24 months and 60 months post procedure
3

Graft incorporation

Assessment of graft incorporation using Magnetic Resonance Imaging (MRI)

Time frame
12 months, 24 months and 60 months post procedure
4

12-item Veterans RAND (VR-12)

Change from baseline (pre-operative) The instrument is primarily used to measure health related quality of life, to estimate disease burden and to evaluate disease-specific benchmarks with other populations. The 12 items are summarized into two scores, a "Physical Health Summary Measure" and a "Mental Health Summary Measure."

Time frame
3 months, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months post procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.